A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which is the causative agent of coronavirus disease 2019 (COVID-19), has …

INTRODUCTION The emergence of three lethal coronaviruses in <20 years and the urgency
of the COVID-19 pandemic have prompted efforts to develop new therapeutic strategies, …

Repurposing drugs as treatments for COVID-19, the disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning with …

The σ 2 receptor has attracted intense interest in cancer imaging 1 , psychiatric disease 2 ,
neuropathic pain 3 , 4 – 5 and other areas of biology 6 , 7 . Here we determined the crystal …

Influenza A Virus (IAV) is a recurring respiratory virus with limited availability of antiviral
therapies. Understanding host proteins essential for IAV infection can identify targets for …

An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19
respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, …

The attentional spatial-numerical association of response codes (Att-SNARC) effect (Fischer,
Castel, Dodd, & Pratt, 2003)—the finding that participants are quicker to detect left-side …

To fight COVID-19, much effort has been directed toward in vitro drug repurposing. Here, we
investigate the impact of colloidal aggregation, a common screening artifact, in these …

Gigantopyramidal neurons, referred to as Betz cells in primates, are characterized by large
somata and extensive basilar dendrites. Although there have been morphological …

Repurposing drugs as treatments for COVID-19 has drawn much attention. A common strategy
has been to screen for established drugs, typically developed for other indications, that …